secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rafael Holdings, Inc. (RFL)
CIK:        0001713863
Form:       8-K
Filed at:   2025-04-24T23:59:59+00:00
Accession:  0001213900-25-035089
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rafael Holdings CEO Bill Conkling to step down; Executive Chairman Howard Jonas to become CEO
--------------------------------------------------------------------------------

- William Conkling resigns as CEO and President effective May 31, 2025; Howard Jonas appointed CEO and President effective June 1, 2025.
- Conkling to receive consulting agreement with $100,000 annual fee and accelerated vesting of options and restricted stock; no cash severance.
- Company focuses on Trappsol Cyclo for Niemann-Pick Disease Type C1; Phase 3 TransportNPC trial 48-week interim analysis expected mid-2025.
- Conkling led merger with Cyclo Therapeutics prior to departure; Jonas previously served as CEO from 2018 to 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1713863/000121390025035089/0001213900-25-035089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1713863/000121390025035089/ea0239411-8k_rafael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-035089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer